Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein
Identifieur interne : 000765 ( PascalFrancis/Curation ); précédent : 000764; suivant : 000766Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein
Auteurs : WAI HAUNG YU [États-Unis] ; Beatriz Dorado [États-Unis] ; Helen Yvette Figueroa [États-Unis] ; LILI WANG [États-Unis] ; Emmanuel Planel [Canada] ; Mark R. Cookson [États-Unis] ; Lorraine N. Clark [États-Unis] ; Karen E. Duff [États-Unis]Source :
- The American journal of pathology [ 0002-9440 ] ; 2009.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Macroautophagy is an essential degradative pathway that can be induced to clear aggregated proteins, such as those found in Parkinson's disease and dementia with Lewy bodies, a form of Parkinsonism. This study found that both LC3-II and beclin were significantly increased in brains from humans with Dementia with Lewy bodies and transgenic mice overexpressing mutant α-synuclein, as compared with respective controls, suggesting that macroautophagy is induced to remove α-syn, particularly oligomeric or mutant forms. Aged mutant animals had higher autophagy biomarker levels relative to younger animals, suggesting that with aging, autophagy is less efficient and requires more stimulation to achieve the same outcome. Disruption of autophagy by RNA interference significantly increased α-syn oligomer accumulation in vitro , confirming the significance of autophagy in α-syn clearance. Finally, rotenone-induced α-syn aggregates were cleared following rapamycin stimulation of autophagy. Chronic rotenone exposure and commensurate reduction of metabolic activity limited the efficacy of rapamycin to promote autophagy, suggesting that cellular metabolism is critical for determining autophagic activity. Cumulatively, these fmdings support the concept that neuronal autophagy is essential for protein homeostasis and, in our system, reduction of autophagy increased the accumulation of potentially pathogenic α-synuclein oligomers. Aging and metabolic state were identified as important determinants of autophagic activity. This study provides therapeutic and pathological implications for both synucleinopathy and Parkinson's disease, identifying conditions in which autophagy may be insufficient to degrade α-syn aggregates.
| pA |
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000527
Links to Exploration step
Pascal:09-0338883Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein</title><author><name sortKey="Wai Haung Yu" sort="Wai Haung Yu" uniqKey="Wai Haung Yu" last="Wai Haung Yu">WAI HAUNG YU</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Dorado, Beatriz" sort="Dorado, Beatriz" uniqKey="Dorado B" first="Beatriz" last="Dorado">Beatriz Dorado</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Yvette Figueroa, Helen" sort="Yvette Figueroa, Helen" uniqKey="Yvette Figueroa H" first="Helen" last="Yvette Figueroa">Helen Yvette Figueroa</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Lili Wang" sort="Lili Wang" uniqKey="Lili Wang" last="Lili Wang">LILI WANG</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Planel, Emmanuel" sort="Planel, Emmanuel" uniqKey="Planel E" first="Emmanuel" last="Planel">Emmanuel Planel</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Centre Hospitalier de l'Universite Laval Neurosciences</s1><s2>Québec</s2><s3>CAN</s3><sZ>5 aut.</sZ></inist:fA14><country>Canada</country></affiliation></author><author><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Gene Expression Unit, National Institutes of Health</s1><s2>Bethesda, Maryland</s2><s3>USA</s3><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Clark, Lorraine N" sort="Clark, Lorraine N" uniqKey="Clark L" first="Lorraine N." last="Clark">Lorraine N. Clark</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pathology, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Center for Human Genetics, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Duff, Karen E" sort="Duff, Karen E" uniqKey="Duff K" first="Karen E." last="Duff">Karen E. Duff</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pathology, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">09-0338883</idno><date when="2009">2009</date><idno type="stanalyst">PASCAL 09-0338883 INIST</idno><idno type="RBID">Pascal:09-0338883</idno><idno type="wicri:Area/PascalFrancis/Corpus">000527</idno><idno type="wicri:Area/PascalFrancis/Curation">000765</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein</title><author><name sortKey="Wai Haung Yu" sort="Wai Haung Yu" uniqKey="Wai Haung Yu" last="Wai Haung Yu">WAI HAUNG YU</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Dorado, Beatriz" sort="Dorado, Beatriz" uniqKey="Dorado B" first="Beatriz" last="Dorado">Beatriz Dorado</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Yvette Figueroa, Helen" sort="Yvette Figueroa, Helen" uniqKey="Yvette Figueroa H" first="Helen" last="Yvette Figueroa">Helen Yvette Figueroa</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Lili Wang" sort="Lili Wang" uniqKey="Lili Wang" last="Lili Wang">LILI WANG</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Planel, Emmanuel" sort="Planel, Emmanuel" uniqKey="Planel E" first="Emmanuel" last="Planel">Emmanuel Planel</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Centre Hospitalier de l'Universite Laval Neurosciences</s1><s2>Québec</s2><s3>CAN</s3><sZ>5 aut.</sZ></inist:fA14><country>Canada</country></affiliation></author><author><name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Gene Expression Unit, National Institutes of Health</s1><s2>Bethesda, Maryland</s2><s3>USA</s3><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Clark, Lorraine N" sort="Clark, Lorraine N" uniqKey="Clark L" first="Lorraine N." last="Clark">Lorraine N. Clark</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pathology, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Center for Human Genetics, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author><author><name sortKey="Duff, Karen E" sort="Duff, Karen E" uniqKey="Duff K" first="Karen E." last="Duff">Karen E. Duff</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pathology, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country></affiliation></author></analytic><series><title level="j" type="main">The American journal of pathology</title><title level="j" type="abbreviated">Am. j. pathol.</title><idno type="ISSN">0002-9440</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">The American journal of pathology</title><title level="j" type="abbreviated">Am. j. pathol.</title><idno type="ISSN">0002-9440</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acidic protein</term><term>Alpha-synuclein</term><term>Anatomic pathology</term><term>Biological activity</term><term>Clearance</term><term>Metabolism</term><term>Treatment efficiency</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Métabolisme</term><term>Activité biologique</term><term>Efficacité traitement</term><term>Clairance</term><term>Protéine acide</term><term>Alpha-synucléine</term><term>Anatomopathologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Macroautophagy is an essential degradative pathway that can be induced to clear aggregated proteins, such as those found in Parkinson's disease and dementia with Lewy bodies, a form of Parkinsonism. This study found that both LC3-II and beclin were significantly increased in brains from humans with Dementia with Lewy bodies and transgenic mice overexpressing mutant α-synuclein, as compared with respective controls, suggesting that macroautophagy is induced to remove α-syn, particularly oligomeric or mutant forms. Aged mutant animals had higher autophagy biomarker levels relative to younger animals, suggesting that with aging, autophagy is less efficient and requires more stimulation to achieve the same outcome. Disruption of autophagy by RNA interference significantly increased α-syn oligomer accumulation in vitro , confirming the significance of autophagy in α-syn clearance. Finally, rotenone-induced α-syn aggregates were cleared following rapamycin stimulation of autophagy. Chronic rotenone exposure and commensurate reduction of metabolic activity limited the efficacy of rapamycin to promote autophagy, suggesting that cellular metabolism is critical for determining autophagic activity. Cumulatively, these fmdings support the concept that neuronal autophagy is essential for protein homeostasis and, in our system, reduction of autophagy increased the accumulation of potentially pathogenic α-synuclein oligomers. Aging and metabolic state were identified as important determinants of autophagic activity. This study provides therapeutic and pathological implications for both synucleinopathy and Parkinson's disease, identifying conditions in which autophagy may be insufficient to degrade α-syn aggregates.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0002-9440</s0></fA01><fA02 i1="01"><s0>AJPAA4</s0></fA02><fA03 i2="1"><s0>Am. j. pathol.</s0></fA03><fA05><s2>175</s2></fA05><fA06><s2>2</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein</s1></fA08><fA11 i1="01" i2="1"><s1>WAI HAUNG YU</s1></fA11><fA11 i1="02" i2="1"><s1>DORADO (Beatriz)</s1></fA11><fA11 i1="03" i2="1"><s1>YVETTE FIGUEROA (Helen)</s1></fA11><fA11 i1="04" i2="1"><s1>LILI WANG</s1></fA11><fA11 i1="05" i2="1"><s1>PLANEL (Emmanuel)</s1></fA11><fA11 i1="06" i2="1"><s1>COOKSON (Mark R.)</s1></fA11><fA11 i1="07" i2="1"><s1>CLARK (Lorraine N.)</s1></fA11><fA11 i1="08" i2="1"><s1>DUFF (Karen E.)</s1></fA11><fA14 i1="01"><s1>Taub Institute, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Pathology, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ><sZ>8 aut.</sZ></fA14><fA14 i1="03"><s1>Center for Human Genetics, Columbia University</s1><s2>New York, New York</s2><s3>USA</s3><sZ>7 aut.</sZ></fA14><fA14 i1="04"><s1>Centre Hospitalier de l'Universite Laval Neurosciences</s1><s2>Québec</s2><s3>CAN</s3><sZ>5 aut.</sZ></fA14><fA14 i1="05"><s1>Gene Expression Unit, National Institutes of Health</s1><s2>Bethesda, Maryland</s2><s3>USA</s3><sZ>6 aut.</sZ></fA14><fA20><s1>736-747</s1></fA20><fA21><s1>2009</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>2047</s2><s5>354000172514640260</s5></fA43><fA44><s0>0000</s0><s1>© 2009 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>3 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>09-0338883</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>The American journal of pathology</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Macroautophagy is an essential degradative pathway that can be induced to clear aggregated proteins, such as those found in Parkinson's disease and dementia with Lewy bodies, a form of Parkinsonism. This study found that both LC3-II and beclin were significantly increased in brains from humans with Dementia with Lewy bodies and transgenic mice overexpressing mutant α-synuclein, as compared with respective controls, suggesting that macroautophagy is induced to remove α-syn, particularly oligomeric or mutant forms. Aged mutant animals had higher autophagy biomarker levels relative to younger animals, suggesting that with aging, autophagy is less efficient and requires more stimulation to achieve the same outcome. Disruption of autophagy by RNA interference significantly increased α-syn oligomer accumulation in vitro , confirming the significance of autophagy in α-syn clearance. Finally, rotenone-induced α-syn aggregates were cleared following rapamycin stimulation of autophagy. Chronic rotenone exposure and commensurate reduction of metabolic activity limited the efficacy of rapamycin to promote autophagy, suggesting that cellular metabolism is critical for determining autophagic activity. Cumulatively, these fmdings support the concept that neuronal autophagy is essential for protein homeostasis and, in our system, reduction of autophagy increased the accumulation of potentially pathogenic α-synuclein oligomers. Aging and metabolic state were identified as important determinants of autophagic activity. This study provides therapeutic and pathological implications for both synucleinopathy and Parkinson's disease, identifying conditions in which autophagy may be insufficient to degrade α-syn aggregates.</s0></fC01><fC02 i1="01" i2="X"><s0>002B24O</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Métabolisme</s0><s5>02</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Metabolism</s0><s5>02</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Metabolismo</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Activité biologique</s0><s5>03</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Biological activity</s0><s5>03</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Actividad biológica</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Efficacité traitement</s0><s5>05</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Treatment efficiency</s0><s5>05</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Eficacia tratamiento</s0><s5>05</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Clairance</s0><s5>06</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Clearance</s0><s5>06</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Depuración</s0><s5>06</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Protéine acide</s0><s5>08</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Acidic protein</s0><s5>08</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Proteína ácida</s0><s5>08</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Alpha-synucléine</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Alpha-synuclein</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Alfa -sinucleina</s0><s5>09</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Anatomopathologie</s0><s5>11</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Anatomic pathology</s0><s5>11</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Anatomía patológica</s0><s5>11</s5></fC03><fN21><s1>243</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000765 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000765 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:09-0338883
|texte= Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein
}}
| This area was generated with Dilib version V0.6.29. |  |